16:42:17 EST Fri 20 Nov 2026
Enter Symbol
or Name
USA
CA



Cizzle Brands Corp (2)
Symbol CZZL
Close 2026-11-19 C$ 0.325
Market Cap C$ 0,000
Recent Sedar+ Documents

Cizzle Brands prices $15.15M (U.S.) public offering

2026-11-20 13:38 ET - News Release

Mr. John Celenza reports

CIZZLE BRANDS CORPORATION ANNOUNCES PRICING OF US$15,150,000 PUBLIC OFFERING AND NASDAQ LISTING

Cizzle Brands Corp. has priced its underwritten public offering in connection with the uplisting of its common shares to the Nasdaq Capital Market. The company is offering 3.03 million common shares at a public offering price of $5 (U.S.) per share. The company has also granted the underwriter (as defined below) a 45-day option to purchase up to an additional 454,500 common shares, representing 15 per cent of the common shares sold in the offering. The common shares are expected to begin trading on the Nasdaq Capital Market on Nov. 20, 2026, under the symbol CZZL.

The gross proceeds from the offering, before deducting underwriting discounts and commissions, and other estimated offering expenses payable by the company, are expected to be approximately $15.15-million (U.S.), excluding any exercise of the underwriter's option to purchase additional shares. The offering is expected to close on or about Nov. 23, 2026, subject to the satisfaction of customary closing conditions.

The company intends to use the net proceeds of the offering for repayment of a portion of the indebtedness incurred to finance: its acquisition of Flow Water Inc.'s beverage co-manufacturing business; capital expenditures to expand production capacity at The Cwench Hydration Factory in Aurora, Ont., including additional Tetra Pak aseptic filling and packaging capacity, and related plant and equipment; and general corporate purposes, including continuing operations, working capital and growth initiatives. However, the company's management will have broad discretion with respect to the actual use of the net proceeds from the offering.

Joseph Gunnar & Co. LLC is acting as sole bookrunning manager for the offering. Research Capital Corp. is acting as an agent for the sale of common shares in the offering in Canada.

A registration statement on Form F-10 (file No. 333-298427) related to the offering of the common shares described above was filed with the United States Securities and Exchange Commission (SEC) and became effective on Sept. 29, 2026, pursuant to Rule 467(b) under the U.S. Securities Act of 1933, as amended. A copy of the registration statement can be accessed by visiting the SEC website. The common shares are being offered and sold in the United States only by means of a prospectus supplement and the accompanying short form base shelf prospectus dated Oct. 7, 2025, forming part of the registration statement. A final prospectus supplement relating to this offering will be filed with the SEC. When available, a copy of the final prospectus supplement and accompanying base shelf prospectus may be obtained from Joseph Gunnar, prospectus separtment, 40 Wall St., 30th floor, New York, N.Y., 10005, telephone 212-440-9600, e-mail: prospectus@jgunnar.com. Investors may also obtain these documents at no cost by visiting the SEC's website and under the company's profile on SEDAR+.

Before you invest, you should read the prospectus and other documents the company has filed or will file with the SEC for more complete information about the company and the offering.

As previously disclosed, a portion of the offering is being raised in Canada in reliance on the listed issuer financing exemption from the prospectus requirements available under Part 5A.2 of National Instrument 45-106, Prospectus Exemptions, as modified by Coordinated Blanket Order 45-935, Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. An amended and restated offering document containing final pricing for the offering can be accessed in English and French under the company's profile on SEDAR+ and on the company's website. Prospective investors in Canada should read the offering document before making an investment decision concerning the common shares. Any distribution of common shares outside of Canada will be made pursuant to applicable foreign securities laws and the public offering exemption available under British Columbia Instrument 72-503, Distribution of Securities outside British Columbia.

The company also confirms that the consolidation of its outstanding common shares on the basis of one postconsolidation common share for every 25 preconsolidation common shares has taken effect as of Nov. 20, 2026. Trading of the postconsolidation common shares on the Nasdaq Stock Market and Cboe Canada is expected to commence on Nov. 20, 2026, under the existing symbol CZZL. The company's common shares will trade under a new Cusip number (17888V 20 1) and ISIN (CA 17888V 20 1 2). The exercise price and the number of common shares issuable under the company's outstanding warrants and options will be proportionately adjusted to reflect the consolidation. Fractional shares created as a result of the consolidation will be rounded down to the nearest whole share.

Following the consolidation and assuming no additional issuances, the company expects to have approximately 9,217,365 common shares issued and outstanding, prior to rounding for fractional shares and prior to giving effect to the offering.

In connection with the consolidation, the company will not require a letter of transmittal from holders of common shares whose shares are held in book entry or DRS form. All such shareholders will automatically receive the postconsolidation shares to which they are entitled and Odyssey Trust Company, as transfer agent, will distribute the applicable DRS statements. Odyssey Trust Company has confirmed that all common shares of the company held by registered shareholders as of the effective date on Nov. 20, 2026, will be processed. The consolidation remains subject to the policies of Cboe Canada.

The company also announced that it intends to extend the expiry date of 36,419,635 outstanding common share purchase warrants (on a preconsolidation basis) that are currently scheduled to expire at 5 p.m. Toronto time on Nov. 28, 2026, by 12 months, to Nov. 28, 2027. The warrants were originally scheduled to expire on Aug. 28, 2026, and their expiry date was previously extended to Nov. 28, 2026. All other terms of the warrants, including the exercise price of 40 cents per share (on a preconsolidation basis, subject to adjustment in accordance with their terms, including for the consolidation) and the company's right to accelerate the expiry date, will remain unchanged. The warrant extension has been approved by written resolution of disinterested shareholders in accordance with the policies of Cboe Canada and remains subject to acceptance by Cboe Canada.

About Cizzle Brands Corp.

Cizzle Brands is a vertically integrated sports nutrition company that is elevating the game in health and wellness. Through extensive collaboration and testing with leading athletes and trainers across several sports, Cizzle Brands has launched three game-changing brands: (i) Cwench Hydration, a better-for-you sports drink that is now carried in over 6,900 locations in Canada, the United States and Europe; (ii) Spoken Nutrition, a premium brand of athlete-grade nutraceuticals that carry the prestigious NSF Certified for Sport qualification; and (iii) HappiEats, upgrading everyday eats with high performance foods such as Sport Pasta and SnakStars Sport Bites. It also owns and operates the Cwench Hydration Factory, a manufacturing facility that produces Cwench Hydration and other leading beverage brands in Tetra Pak packaging. All Cizzle Brands products are designed to help people of all ages achieve their best in competitive sports and in living a healthy, vibrant, active lifestyle.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.